Osteoarthritis is a disease. While it was long dismissed as simple “wear and tear” on aging joints, the medical understanding has shifted significantly. Osteoarthritis is now recognized as a disease of the entire joint, involving active biological processes like inflammation, abnormal tissue remodeling, and cellular breakdown. It is not just cartilage wearing down over time.
Why “Wear and Tear” Is a Misnomer
For decades, osteoarthritis was commonly called “degenerative joint disease,” which implied that joints simply eroded with use, like brake pads on a car. That label is misleading. Osteoarthritis is an active response to injury, driven by inflammatory molecules within the affected joint. Rather than passively breaking down, the joint tissues are being actively remodeled in harmful ways.
This distinction matters because it changes how the condition is treated and how seriously it’s taken. If osteoarthritis were just mechanical erosion, the only real option would be to wait for a joint replacement. But because it involves biological processes, including inflammation and abnormal cell behavior, there are more avenues for slowing it down or managing it effectively.
What Happens Inside the Joint
Osteoarthritis affects far more than cartilage. It damages bone, the joint lining, ligaments, and even surrounding muscles and tendons. This is why researchers now describe it as “joint failure,” similar to how heart disease can lead to heart failure. Every tissue in the joint is involved.
The process typically starts when cartilage cells, which normally have limited ability to repair themselves, are pushed into overdrive by injury or chronic stress. These cells attempt to multiply and rebuild damaged tissue, but the repair effort goes wrong. They begin producing signals that break down the very structures they’re trying to fix. The protective proteins that give cartilage its cushion-like quality degrade, the collagen network falls apart, and eventually the cartilage cells themselves die off.
Beneath the cartilage, bone responds to the changing mechanical environment by thickening and forming bony growths called osteophytes, the hard lumps you can sometimes feel around an arthritic joint. The bone just below the cartilage surface undergoes abnormal remodeling that can actually accelerate cartilage loss from below, creating a vicious cycle.
The Role of Inflammation
One of the biggest shifts in understanding osteoarthritis has been recognizing the role of chronic, low-grade inflammation. This isn’t the dramatic swelling you’d see with an infected wound. It’s a quieter, persistent process driven by immune cells, particularly a type of white blood cell called macrophages, that accumulate in the joint lining.
These macrophages produce a cascade of inflammatory molecules that are now considered major drivers of ongoing joint destruction. Fragments of damaged cartilage and other joint tissues can trigger this immune response, meaning the disease essentially fuels itself. As cartilage breaks down, the debris activates more inflammation, which causes more breakdown. This self-perpetuating cycle is a key reason osteoarthritis tends to worsen over time rather than stabilize.
How It Differs From Rheumatoid Arthritis
Both osteoarthritis and rheumatoid arthritis cause joint pain, stiffness, and limited mobility. Both involve cartilage damage and inflammation of the joint lining. But the underlying mechanisms are fundamentally different.
Rheumatoid arthritis is an autoimmune disease where the immune system aggressively attacks healthy joint tissue. It features a much more severe immune response, with T cells (a type of immune cell involved in targeted attacks) playing a central role. Blood tests in rheumatoid arthritis typically show significantly elevated inflammatory markers, including rheumatoid factor and antibodies against the body’s own proteins.
In osteoarthritis, inflammatory markers in blood work are usually normal or only mildly elevated. The inflammation is localized to the joint rather than being a system-wide immune malfunction. Interestingly, research has found that osteoarthritis is actually associated with more protective anti-inflammatory signals than rheumatoid arthritis, which is dominated by tissue-damaging ones. This helps explain why osteoarthritis progresses more slowly and why joint destruction in rheumatoid arthritis can be more rapid and severe.
Who Gets Osteoarthritis and Why
Osteoarthritis has both mechanical and metabolic drivers, which is part of what makes it a true disease rather than a simple consequence of aging. The strongest modifiable risk factor is excess body weight. Each unit increase in BMI raises the risk of knee osteoarthritis by about 86% and hip osteoarthritis by about 56%, based on genetic analysis that isolates the effect of weight from other factors.
The mechanism isn’t purely mechanical. If extra weight only damaged joints through physical loading, you’d expect osteoarthritis to affect only weight-bearing joints like knees and hips. But obesity is also linked to osteoarthritis in the hands, which bear almost no body weight. This points to a metabolic component: fat tissue produces inflammatory molecules that circulate through the body and can damage joints regardless of how much load they carry.
Genetics play a significant role as well. Certain gene variants influence cartilage structure, inflammatory signaling, and bone remodeling in ways that predispose some people to the disease. Previous joint injuries, repetitive occupational stress, and age-related changes in how cells repair themselves all contribute. Most cases of osteoarthritis result from several of these factors converging rather than any single cause.
How Osteoarthritis Is Diagnosed
Diagnosis relies on a combination of symptoms and, in many cases, imaging. For hip osteoarthritis, the standard clinical criteria look for joint pain along with specific physical exam findings: reduced internal rotation, morning stiffness lasting less than an hour, and age over 50. When X-rays are added, doctors look for bony growths and narrowing of the space between bones where cartilage should be.
The modern definition of osteoarthritis requires both symptoms reported by the patient (pain, stiffness, reduced function) and structural changes visible on imaging. This dual requirement exists because some people have joint changes on X-ray with no symptoms, while others have significant pain with minimal visible damage. The disease is defined by the combination, not either one alone.
The Broader Burden
Osteoarthritis carries an economic weight that reflects its status as a genuine disease. The average annual cost per person with osteoarthritis ranges from $700 to $15,600, depending on disease severity and healthcare system. In developed economies, the total cost of the disease accounts for roughly 1% to 2.5% of the entire gross national product.
At the individual level, the burden is concrete and measurable. In the five years after a knee osteoarthritis diagnosis, each patient averages about 17 additional healthcare visits, nearly 22 extra disability days, and significantly increased medication use compared to people without the condition. These numbers reflect a disease that reshapes daily life, not a minor inconvenience of aging.